Characterizing the genetic profile of lung adenocarcinomas upon initial diagnosis has become a critical step in guiding the management and treatment of patients. The need for detection of multiple biomarkers in a single, limited diagnostic sample has driven the adoption of two complementary technologies at Houston Methodist Hospital. In this AMP 2023 workshop, Dr. Jessica S. Thomas, Assistant Professor of Clinical Pathology and Genomic Medicine, shares how Methodist delivers significantly accelerated results and a higher success rate for low cellularity samples by supplementing NGS with the MassARRAY platform. She discusses how this testing paradigm has impacted patients and key considerations for implementation.
Jessica S. Thomas, MD, PhD, MPH
Associate Medical Director, Molecular Pathology Diagnostic Laboratory
Houston Methodist Hospital
Recorded on November 15, 2023.
Learn more about our tumor profiling solutions.